COVID-19-associated pancytopenia can be self-limiting and does not necessarily warrant bone marrow biopsy for the purposes of SARS-CoV-2 diagnostics

por Hersby, D.S., Do, T.H., Gang, A.O., Nielsen, T.H.
Publicado 2021

PB2005: BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: A REAL-WORLD STUDY OF CHINA

por Jingyu, X., Wenqiang, Y., Huishou, F., Jiahui, L., Lingna, L., Lugui, Q., Gang, A.
Publicado 2022

Regulatory B cell-myeloma cell interaction confers immunosuppression and promotes their survival in the bone marrow milieu

por Zhang, L, Tai, Y-T, Ho, M, Xing, L, Chauhan, D, Gang, A, Qiu, L, Anderson, K C
Publicado 2017

P910: DOES MINIMAL RESIDUAL DISEASE OF STEM CELL COLLECTION HAVE PROGNOSTIC IMPACT ON PATIENTS WITH MULTIPLE MYELOMA?

por Jingyu, X., Wenqiang, Y., Huishou, F., Jiahui, L., Lingna, L., Chenxing, D., Shuhui, D., Weiwei, S., Yan, X., Lugui, Q., Gang, A.
Publicado 2022

5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies

por Gang, A O, Frøsig, T M, Brimnes, M K, Lyngaa, R, Treppendahl, M B, Grønbæk, K, Dufva, I H, Straten, P thor, Hadrup, S R
Publicado 2014